CGS 21680, dibutyryl cyclic AMP and rolipram attenuate the pro-inflammatory interactions of the Pseudomonas aeruginosa -derived pigment, 1-hydroxyphenazine, with human neutrophils

Pulm Pharmacol Ther. 2000;13(6):293-9. doi: 10.1006/pupt.2000.0257.

Abstract

The effects of the intracellular adenosine 3':5' cyclic monophosphate (cAMP)-elevating agents, CGS 21680 (0.01- 1 microM) and rolipram (0.01-1 microM), as well as those of dibutyryl cAMP (0. 05-4 mM) on the pro-inflammatory interactions of the P. aeruginosa -derived pigment, 1-hydroxyphenazine (1-hp, 3.1 and 12.5 microM), with human neutrophils have been investigated in vitro. Ca(2+)fluxes in FMLP-activated neutrophils were measured using a fura-2/AM spectrofluorimetric procedure, while a colourimetric method was used to measure release of the primary granule enzyme, elastase, from the cells. Treatment with 1-hp resulted in delayed clearance of Ca(2+)from the cytosol of N -formyl- L -methionyl- L -leucyl- L -phenylalanine (FMLP, 1 microM)-activated neutrophils and increased release of elastase. All 3 test agents caused dose-related antagonism of 1-hp-mediated potentiation of elastase release from activated neutrophils, which was associated with restoration of Ca(2+)homeostasis. These observations demonstrate the potential of cAMP-elevating agents, acting on Ca(2+)clearance mechanisms in activated neutrophils, to attenuate the potentially harmful pro-inflammatory effects of 1-hp.

Publication types

  • Comparative Study

MeSH terms

  • Adenosine / administration & dosage
  • Adenosine / analogs & derivatives*
  • Adenosine / pharmacology*
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / pharmacology*
  • Bucladesine / administration & dosage
  • Bucladesine / pharmacology*
  • Calcium / metabolism
  • Calcium Channels / drug effects
  • Calcium Channels / physiology*
  • Dose-Response Relationship, Drug
  • Homeostasis
  • Humans
  • Neutrophils / drug effects*
  • Neutrophils / immunology
  • Phenazines / metabolism*
  • Phenethylamines / administration & dosage
  • Phenethylamines / pharmacology*
  • Phosphodiesterase Inhibitors / administration & dosage
  • Phosphodiesterase Inhibitors / pharmacology*
  • Pseudomonas aeruginosa*
  • Rolipram / administration & dosage
  • Rolipram / pharmacology*

Substances

  • Antihypertensive Agents
  • Calcium Channels
  • Phenazines
  • Phenethylamines
  • Phosphodiesterase Inhibitors
  • 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine
  • 1-hydroxyphenazine
  • Bucladesine
  • Rolipram
  • Adenosine
  • Calcium